International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels
about
A nomenclature for ligand-gated ion channelsAn amino acid outside the pore region influences apamin sensitivity in small conductance Ca2+-activated K+ channelsMolecular targets for antiepileptic drug developmentAlterations in reversible protein histidine phosphorylation as intracellular signals in cardiovascular diseaseOxidative Stress and Maxi Calcium-Activated Potassium (BK) ChannelsNeuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and PitfallsObstructing toxin pathways by targeted pore blockageFunction and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cellsThe opportunities and challenges of large-scale molecular approaches to songbird neurobiology.Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potentialNovel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesDefinitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factorGenomics analysis of potassium channel genes in songbirds reveals molecular specializations of brain circuits for the maintenance and production of learned vocalizations.Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1)Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells.K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy.The Concise Guide to PHARMACOLOGY 2013/14: ion channelsKalium: a database of potassium channel toxins from scorpion venom.Kv3-like potassium channels are required for sustained high-frequency firing in basal ganglia output neurons.De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.Disruption of the aortic elastic lamina and medial calcification share genetic determinants in mice.Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and SecretionDifferential molecular information of maurotoxin peptide recognizing IK(Ca) and Kv1.2 channels explored by computational simulation.Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladderTwo distinct pools of large-conductance calcium-activated potassium channels in the somatic plasma membrane of central principal neuronsThe activation effect of hainantoxin-I, a peptide toxin from the Chinese spider, Ornithoctonus hainana, on intermediate-conductance Ca2+-activated K+ channels.New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.Calcium-activated potassium current modulates ventricular repolarization in chronic heart failure.Spider-venom peptides as bioinsecticides11,12-EET stimulates the association of BK channel α and β(1) subunits in mitochondria to induce pulmonary vasoconstriction.Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levelsIon channel pharmacology.Synaptic NMDA receptor-dependent Ca²⁺ entry drives membrane potential and Ca²⁺ oscillations in spinal ventral horn neurons.A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents.Intermediate conductance Ca2+-activated K+ channels modulate human placental trophoblast syncytializationHigh expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.Modulation of K(Ca)3.1 channels by eicosanoids, omega-3 fatty acids, and molecular determinants
P2860
Q24609005-5455F5D4-F473-43DD-AB41-9FF6AADBDC67Q24669897-EBF749A8-4660-4610-9CD1-6610BEAAF3DCQ24683346-575517E5-AFA0-48B9-8C39-933FADEF1412Q26782883-B1C1D55E-5FDC-4B69-B390-D0BA4852CC93Q26796569-2C83EDA6-3C5D-4559-9705-2ACD7606ED3CQ26798018-85A2710A-82EC-4176-9BA5-CC90B1DA6818Q26827489-89E368BE-AF42-4E17-ABD1-DA4D945198E8Q26995779-8A340B6E-0EC8-4F33-A0CE-66BE999F6C2CQ27010249-3A352749-FA0C-4694-85BC-9F90E747D411Q28080655-D3C9739F-A242-4D61-BA48-947066A49757Q28488052-1411C9FE-6DB0-4626-8398-7FF092B0BFD5Q28553394-F4D0BDA5-CA0E-476F-8275-908AA823F4FCQ28582616-47C07048-E24E-40D0-9675-53029DBFDE91Q28678092-4E8DD965-E7AB-42B7-9F1B-B0B654DFD9A7Q28833834-848E7661-F288-4361-8DCB-DD38FEA17D35Q30276331-18BA1E1F-1AAB-4894-A3D2-45EFD87F7DA9Q30449041-80DEC29F-EC47-431F-ACEE-56EC323C7008Q30486735-F01910A5-55F2-4C45-805B-5A97511A3F40Q30489239-63EB4D29-789E-4DF7-B44D-CBF73FA8A4A5Q30498803-0E6C4B86-AEFC-4B84-9362-3A676429A904Q30540814-FC0FB542-FC96-4958-86B3-5D5A21DBCF01Q33654786-C4367300-AE52-48AA-87C3-210B101BE4E2Q33717822-DA980079-7D46-45EA-A3E5-4AD97048DDDFQ33780658-D947062B-F931-4A54-9DA8-B63F6B837EB1Q33801747-A60B9F7D-3358-4F1B-BB9E-2C395973E826Q33841023-82F3B431-4EAE-4E61-88DF-07B0399F613AQ34073523-466F21F8-5A3C-4270-85EA-4FFE8154F13FQ34101834-4A78B6E0-A24B-42D6-91D2-55F32E78DFF1Q34125233-A72FAE62-8A76-4A3A-8D5E-1D65C5A80134Q34278261-14626A46-578D-4D16-818E-994559DA6CA3Q34319661-9C5A865D-E861-48FE-BBA1-83CD0E2D55CBQ34430758-945B5A59-9DF0-426B-9EC8-32E9BE6460D4Q34451073-DA816BC7-59B7-441B-9431-A3CE95A0EC97Q34613758-79E1CE86-CB17-42DD-B474-7E6964333A58Q34707072-1898C809-A543-451B-98C5-735F328CB2EBQ34946861-A356BEFE-3024-4F78-BDF2-3503D6192623Q35055551-788B9E60-9F88-49B4-B77C-ABA1A3A91C92Q35111345-57B075D7-CE19-4FA4-BE0D-C36C7A8AF387Q35304761-CE04CB27-CD7D-4E04-84DC-FB728A565F2CQ35395940-77D30A51-C139-4C9C-A8FB-E61CFBD5B2E4
P2860
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
International Union of Pharmac ...... m-activated potassium channels
@ast
International Union of Pharmac ...... m-activated potassium channels
@en
International Union of Pharmac ...... m-activated potassium channels
@nl
type
label
International Union of Pharmac ...... m-activated potassium channels
@ast
International Union of Pharmac ...... m-activated potassium channels
@en
International Union of Pharmac ...... m-activated potassium channels
@nl
prefLabel
International Union of Pharmac ...... m-activated potassium channels
@ast
International Union of Pharmac ...... m-activated potassium channels
@en
International Union of Pharmac ...... m-activated potassium channels
@nl
P2093
P3181
P356
P1476
International Union of Pharmac ...... m-activated potassium channels
@en
P2093
Aguan D Wei
George A Gutman
Heike Wulff
K George Chandy
Richard Aldrich
Stephan Grissmer
P304
P3181
P356
10.1124/PR.57.4.9
P407
P577
2005-12-01T00:00:00Z